Finland· FI-REL-REL51466
Bosulif
A bosutinib product containing bosutinib monohydrate, registered in Finland by Pfizer Europe MA EEIG. The same ATC class is registered in 15 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Bosutinib is registered in 15 of 19 countries.
Countries holding a registration under ATC L01EA04 (bosutinib), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Bosutinib · ATC L01EA04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bosutinib costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bosutinib · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$65.58
The record
At a glance
Fimea (Finland)- Active substance
- Bosutinib monohydrate
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Finland (FI)
- ATC code
- L01EA04
- ATC class
- Bosutinib
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa55841728EUR 1182.16
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
469 interactions on record for bosutinib.
Graded by severity as the source publishes them — 159 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bosutinib · interactions on record
469 records
- 159 severe
- 307 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- AprepitantA04AD12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bosutinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBOSULIFPfizer Europe MA EEIG, Bruxelles
- SwedenBosulif 400 mg Filmdragerad tablettPfizer Europe MA EEIG
- IcelandBosulifPfizer Europe MA EEIG*
- NetherlandsBosulif 400 mg, filmomhulde tablettenPfizer Europe MA EEIG
- SpainBOSULIF 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPfizer Europe Ma Eeig
- FranceBOSULIF 400 mg, comprimé pelliculéPFIZER EUROPE MA EEIG (BELGIQUE)
- PolandBosulifPfizer Europe MA EEIG
- NorwayBosulifAbacus Medicine A/S
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Bosutinib Sandoz, Bosutinib Teva
- Belgium · Bosutinib Eg, Bosutinib Eg (Eurogeneric)
- Bulgaria · Босутиниб Msn, Босутиниб Зентива
- Czechia · Bosutinib Msn, Bosutinib Teva
- Germany · Bosutinib, Bosutinib Al
- Denmark · Bosutinib Newbury, Bosutinib Sandoz
- Estonia · Bosutinib Msn
- Spain · Bosutinib, Bosutinib Vivanta
- France · Bosutinib Biogaran, Bosutinib Eg Labo
- United Kingdom (Northern Ireland) · Bosutinib Dr. Reddy’s, Bosutinib Stada
- Croatia · Bosutinib Msn, Bosutinib Onkogen
- Hungary · Bosutinib Onkogen, Bosutinib Sandoz
- Ireland · Bosutinib Clonmel, Bosutinib Rowex
- Iceland · Bosulif, Bosutinib Beta
- Italy · Bosutinib Dr. Reddys, Bosutinib Eg
- Liechtenstein · Bosulif
- Lithuania · Bosutinib Msn
- Luxembourg · Bosutinib Eg
- Latvia · Bosutinib Msn
- Malta · Bosutinib, Bosutinib Lotus
- Netherlands · Bosutinib, Bosutinib Cf
- Norway · Bosulif, Bosutinib Newbury
- Poland · Bosutinib Msn, Bosutinib Onkogen
- Portugal · Bosutinib Teva
- Romania · Bosutinib Teva
- Sweden · Bosutinib Newbury, Bosutinib Sandoz
- Slovenia · Bosutinib Msn
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb92afa0-8ff4-4c5f-ac4b-a40a3e819bc3 GET /v1/drugs/cb92afa0-8ff4-4c5f-ac4b-a40a3e819bc3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.4",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "400 mg",
"atc_label": "bosutinibi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/13/818/006-007",
"fimea_rel_id": "REL51466",
"authorised_at": "2018-05-22"
}See everything about bosutinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.